期刊文献+

青少年溃疡性结肠炎的临床分析 被引量:1

下载PDF
导出
摘要 目的总结青少年溃疡性结肠炎的临床特点和治疗效果。方法统计我科住院青少年溃疡性结肠炎50例患者的相关资料。结果青少年溃疡性结肠炎以腹痛、腹泻、黏液血便为主要临床症状,本组病理组织检查未发现癌变者,治疗以内科用药治疗为主,4例并发穿孔转手术治疗,青少年男性患者多于女青年。结论溃疡性结肠炎在青少年期因其肠道表现在初期可能不明显或很轻,有较高漏诊、误诊率。临床主要表现以腹泻、血便或脓血便为主,儿童关节炎等肠道外症状少见,主要并发症为肠、肠狭窄、肠穿孔和中毒性巨结肠,病程越长癌变倾向越高。
作者 姚海峰
出处 《中国医药指南》 2015年第10期172-173,共2页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献41

  • 1Bitton A.Medical management of ulcerative proctitis,proctosigmoiditis,and left-sided colitis.Semin Gastrointest Dis 2001; 12:263-274.
  • 2Farmer RG,Easley KA,Rankin GB.Clinical patterns,natural history,and progression of ulcerative colitis.A long-term follow-up of 1116 patients.Dig Dis Sci 1993; 38:1137-1146.
  • 3Safdi M,DeMicco M,Sninsky C,Banks P,Wruble L,Deren J,Koval G,Nichols T,Targan S,Fleishman C,Wiita B.A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.Am J Gastroenterol 1997; 92:1867-1871.
  • 4Kane S,Huo D,Aikens J,Hanauer S.Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.Am JMed 2003; 114:39-43.
  • 5Prantera C,Viscido A,Biancone L,Francavilla A,Giglio L,Campieri M.A new oral delivery system for 5-ASA:preliminary clinical findings for MMx.Inflamm Bowel Dis 2005; 11:421-427.
  • 6Tenjarla S,Romasanta V,Zeijdner E,Villa R,Moro L.Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system.Adv Ther 2007; 24:826-840.
  • 7D'Haens G,Hommes D,Engels L,Baert F,van der Waaij L,Connor P,Ramage J,Dewit O,Palmen M,Stephenson D,Joseph R.Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis:a phase II,dose-ranging study.Aliment Pharmacol Ther 2006; 24:1087-1097.
  • 8Brunner M,Assandri R,Kletter K,Tschurlovits M,Corrado ME,Villa R,Eichler HG,Muller M.Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation.Aliment Pharmacol Ther 2003; 17:395-402.
  • 9Lichtenstein GR,Kamm MA,Boddu P,Gubergrits N,Lyne A,Butler T,Lees K,Joseph RE,Sandborn WJ.Effect of once-or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.Clin Gastroenterol Hepatol 2007; 5:95-102.
  • 10Kamm MA,Sandborn WJ,Gassull M,Schreiber S,Jackowski L,Butler T,Lyne A,Stephenson D,Palmen M,Joseph RE.Once-daily,high-concentration MMX mesalamine in active ulcerative colitis.Gastroenterology 2007; 132:66-75; quiz 432-433.

共引文献1178

同被引文献12

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部